Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(18 sites)

France

CHU d'Amiens, Amiens, France

CHU de Caen, Caen, France

Polyclinique du Parc Drevon, Dijon, France

CH Annecy Genevois, Epagny Metz- Tessy, France

CHU de Lille, Lille, France

Centre Léon Bérard, Lyon, France

CHU de Montpellier, Montpellier, France

Hôpital Saint-Louis, Paris, France

Hôpital Saint-Antoine, Paris, France

Hôpital Necker, Paris, France

CHU de Bordeaux, Pessac, France

CHU de Lyon, Pierre-Bénite, France

CHU de Poitiers, Poitiers, France

CHU de Rennes, Rennes, France

CH Saint-Etienne, Saint-Priest-en-Jarez, France

CHU de Toulouse, Toulouse, France

CHU de Tours, Tours, France

CHRU Nancy, Vandœuvre-lès-Nancy, France